Search results for: Genetic
Filter search results
Cystic Fibrosis
1 March 1986
Cystic Fibrosis (CF) is the most common genetically determined disease in Britain. Each year about 400 infants are born with the disorder and of these probably less than 25 per…
An eye on sustainability at the Economist’s Future of Health Europe
30 October 2023
…Future Health) shared how they are currently collating information on genetic susceptibility into a database, to facilitate early diagnosis and delayed disease progression. This is a prime example of how…
OHE Involved in Developing New AMS Report on Stratified Medicines
15 July 2013
…For example, it can identify the 2–9% of patients who have a genetic biomarker for hypersensitivity to Ziagen® (abacavir), an HIV medication, thereby avoiding severe reactions. Similarly, Xalkori® (crizotinib) is…
Obesity
1 July 1994
…most, or all, of the following factors: (1) an ample food supply; (2) a sedentary lifestyle; (3) psychological and behavioural factors; and (4) genetic or metabolic factors. Evidence will be…
Huntington’s Chorea
1 March 1980
…in genetic counselling services and methods of identifying the genetic aberration responsible for Huntington’s chorea. New research into the characteristics of cells from affected subjects together with the recent advent…
Spotlight on OHE: Understanding Value Based Pricing
12 February 2013
…applications—where he discussed approaches to valuing genomic medicines. The conference was sponsored by the NHS Genetics Education and Development Centre; it focused on opportunities and challenges for translational genomics from…
Why do we expect obesity medicines to work differently?
5 March 2026
…obesity as “a chronic, relapsing disease arising from complex interactions between genetics, neurobiology, eating behaviours, access to healthy diet, market forces, and the broader environment”. A symptom of obesity is…
Katherine Payne
30 January 2024
…started when she worked as the health economist for the North West Genetics Knowledge Park (Nowgen) between 2003 and 2007. In September 2007, Katherine was awarded a five-year Research Councils…
OHE Lunchtime Seminar: Early Experience with HTA of Gene Therapies in the US: Pricing and Paying for Cures
21 October 2018, 11:00pm
…haemophilia, sickle cell disease, and numerous other genetically-based conditions. Individually, each treatment will be extremely expensive, and in the aggregate their costs are projected to have a substantial impact on…